Intellectual Property and Trade

  • Your Selections:

Refine Results

date

Tags

HIV Prevention Group Files Petition With U.S. Patents Office Alleging Gilead Delayed Improved HIV Drug Development To Gain Profits From Older Medicines

Washington Post: Gilead delayed safer HIV drug to extend monopoly profits, advocates allege “…An HIV-prevention group called PrEP4All Collaboration filed a petition Wednesday with the U.S. Patent and Trademark Office contending Gilead knew its new, improved drug — approved in 2015 and now part of Gilead’s combination therapies Genvoya and…

More News In Global Health

Al Jazeera: Nigeria urged to ban chaining people with mental health issues (11/11). Borgen Magazine: Bill Gates on Decreasing Global Poverty (Dobson, 11/9). Deutsche Welle: Drug addiction in Russia: Draconian laws instead of help (Kauschanski, 11/11). Devex: A remote Congolese island offers a test case for improving the country’s health…

Media Outlets Continue Coverage Of Trump Administration’s Lawsuit Against Gilead Over Patent Infringements On PrEP Medicines

Axios: Federal lawsuit against Gilead puts patent rights on trial (Herman, 11/8). Financial Times: U.S. sues Gilead over HIV patent infringements (Mancini, 11/7). The Hill: Trump administration sues HIV prevention drug maker for patent infringement (Sullivan, 11/7). STAT: HHS sues Gilead for refusing to reach a licensing deal over patents…

Trump Administration Files Patent Infringement Lawsuit Against Gilead Over HIV PrEP Drugs

New York Times: Trump Administration Sues Gilead, Maker of HIV-Prevention Drugs “The Trump administration on Wednesday sued Gilead Sciences, a pharmaceutical company that sells HIV-prevention drugs that can cost patients up to $20,000 a year [in the U.S.], accusing the company of earning billions from research funded by taxpayers without…

9 African Nations Begin Work Toward Pooled Procurement Of Vaccines, WHO Regional Office Notes

WHO Regional Office for Africa: Nine African countries agree to begin journey towards pooled procurement to increase their access to affordable life-saving vaccines “Nine middle-income countries in Africa have agreed to work towards pooled procurement mechanisms by first sharing vital information on their vaccine purchasing practices, including the prices they…

More News In Global Health

Borgen Magazine: The End Tuberculosis Now Act of 2019 (Gordon, 10/19). Los Angeles Times: Measles making a deadly comeback across Africa (Mahr, 10/20). New Dawn: Ellen Johnson Sirleaf’s vision for global health (10/17). New York Times: Venezuela’s Water System is Collapsing (Kurmanaev/Herrera, 10/19). NPR: Where You’re Born Even Within A…

Differential Pricing Of Drugs Must Involve Collaboration Among All Stakeholders

STAT: Where was differential pricing at the WHO Fair Pricing Forum? Ed Schoonveld, managing principal and leader of the value and access practice at ZS Associates “…The complexity of the economics of drug development and lack of transparency about drug prices and R&D investments is infuriating many stakeholders. That sentiment…